Level D· Scientific groundwork from lab and animal studiesAnimal StudyPubMed

Effect of human adipose derived stem cells on scar formation and remodeling in a pig model: a pilot study.

Yun IS., Jeon YR., Lee WJ., Lee JW., Rah DK., Tark KC.

Animal Study on Chronic Wound, Scar, published in Dermatol Surg (2012) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Animal Study
Journal
Dermatol Surg (2012)
Country
United States
Reported sample size
—
Source database
PubMed
PMID
22804839
DOI
10.1111/j.1524-4725.2012.02495.x
Citations
91

Abstract (original English)

Background Adipose-derived stem cells (ASCs) have positive effects in the wound healing process. Objective To clarify whether ASCs positively mitigate scar formation in the wound remodeling process. Materials and methods Full-thickness skin defects were created on the dorsal skin of Yorkshire pigs. After the defects were transformed into early scars, ASCs were injected, and the same amount of phosphate buffered saline (PBS) was injected in the control group. Clinical and histologic examinations were performed. Results In the experimental group, the areas of scars were smaller than those of control groups. The color of scars was more similar to that of the surrounding normal tissue, and scar pliability was better. The number of mast cells decreased, and more-mature collagen arrangement was noted. In the early period of scar remodeling, the expression of transforming growth factor beta (TGF-β)3 and matrix metalloproteinase 1 (MMP1) was greater in the experimental group than in control group. In the late period, the level of alpha smooth muscle actin and tissue inhibitor of metalloproteinase 1 were dramatically less, although the level of MMP1 was lower in the experimental group than in control group. Conclusions Local injection of ASCs decreases scar size and provides better color quality and scar pliability. It decreases the activity of mast cells and inhibits the action of TGF-

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
ActinsAdipose TissueAnimalsCell CountCicatrixCollagenColorHumansMaleMast Cells

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research